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Natural nucleosides and especially their modified analogues either directly or as 
intermediates are of great pharmaceutical interest in the development of antiviral and 
antitumour agents. Modified nucleosides are classical antiviral drugs, commonly used in 
the treatment of herpes virus and HIV infections. They usually act as chain terminators 
in viral nucleic acid replication, although in some cases other mechanisms have been 
suggested, such as inhibition of RNA capping or hypermutagenesis of viral nucleic 
acids [15]  
 
Nucleosides bearing different modifications either on the ribofuranosyl moiety or on the 
sugar-linked heterocyclic nitrogen bases can be prepared by chemical synthesis through 
multistage processes requiring protection and deprotection of labile groups. These 
synthetic approaches are often accompanied by low overall yields and by formation of 
regio- and stereo- isomers. The biocatalyst technology has many advantages over 
synthetic approaches in producing structurally complicated fine chemicals like most 
pharmaceuticals. 
 
Biocatalysis usually replaces multi-step chemical processes and minimize energy 
consumption and disposal of waste, and subsequently the cost of the final product. 
It also allows production of novel bioorganic molecules, which can‟t be synthesized. 
This work is related to the research project „Biocatalysts for producing pharmaceutical 
nucleoside analogues“, where the biocatalysis utilising the enzyme Purine nucleoside 
phosphorylase (PNP) is used for producing purine nucleoside analogues. This study is 
focused on analysing of these two enzymes - Purine nucleoside phosphorylase and 
Thymidine phosphorylase and especially on analysing their binding properties using a 
phenomenon of surface plasmon resonance in Biacore X instrument. 
 
The whole project has several participants; they are University of Kuopio, University of 
Oulu and University of Helsinki. This study was performed in the group of University 
of Kuopio, which is developing biocatalysts for the synthesis of nucleosides and their 




1. REVIEW OF LITERATURE 
 
1.1 SURFACE PLASMON RESONANCE ANALYSIS 
 
Surface plasmon resonance (SPR) is a non-invasive optical measuring technique which 
measures the mass concentration of biomolecules on the sensor surface. SPR causes a 
reduction in the reflected light intensity at a specific combination of angle and 
wavelength (generating a refractive index dependent SPR signal). The technique does 
not require any labelling of the interacting components. The response is essentially 
independent of the nature of the biomolecule, so that all steps in an interaction analysis 
are followed with the same criterion. 
 
Biacore X is a semi-automated system for analyzing interactions between biomolecules 
and their ligands using a phenomenon of surface plasmon resonance. In Biacore 
terminology, a molecule, which is immobilized to the surface of the sensor chip, is 
called ligand and the other one, which is free in the solution flowing over the surface, is 
called analyte. 
 
Biacore X provides high sensitivity in small consumption of samples and allows 
measuring wide range of biomolecules - from purified molecules to crude samples, like 
lipid vesicles, viruses, bacteria and eukaryotic cells. 
 Usual types of analyses are specificity analysis, multiple binding analysis, 
concentration analysis, affinity and kinetic analysis, studies of enzymatic processes and 
studies of structure-function relationships. 
       Specificity analysis answers the question if the molecule is specific for its target. 
       Multiple binding analysis investigates how different components in a complex 
bind to each other. 
       Concentration analysis gives the answer of how much analyte is there in a sample. 
       Affinity and kinetic analyses deal with strength of binding between ligand and 
analyte and with velocity of association and dissociation of the complex. 
       Studies of enzymatic processes involve proteolysis, phosphorylation, nucleic acid 
synthesis, ligation and cleavage. 
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       Studies of structure-function relationship elucidate functional changes according 
to structural modifications and variations in a molecule. 
 
Biacore X technology consists of three main parts. They are microfluidics, the sensor 
chip and the SPR detection. 
 
  Microfluidics 
 
 The microfluidic system consists of a series of channels and valves in a plastic block, 
the Integrated µ-Fluidic Cartridge (IFC). The flow cells are formed by pressing the 
sensor chip against a set of open channels on the surface of the IFC, so that the chip can 
easily be exchanged. Delivery of sample and buffer to the flow cells is precisely 
controlled by the pump system and the valves in the IFC. In this way, a continuous flow 
of liquid is maintained over the sensor surface throughout the analysis, switching 
between buffer and sample with minimum disturbance or dispersion of the sample 
boundary. This precision in sample delivery is very important for reproducibility of 
assay procedures, and also provides the control conditions necessary for interpreting 
kinetic data obtained from the interaction studies.  
 There are two flow cells in Biacore X and they can be used individually or in the series. 
When used individually, two different ligands can be immobilized. But when used in 
series, one of them serves for immobilization and the other serves as a reference. The 
in-line reference subtraction runs automatically. The microfluidic system is miniaturized 
and designed to use as little as 5µl of sample, while volume of the cell is 0.06µl. The 
whole system is in a temperature controlled environment, liquid handling is automated 
and integrated. Elimination of air/liquid interfaces minimizes sample dispersion and 
protein denaturation. 
 
  The Biacore Sensor chip 
 
 The surface of the sensor chip serves to immobilize of the ligand and it also creates one 
wall of the flow cell. The chip provides the physical conditions necessary to generate 
the SPR signal and all the interactions which are studied take place on its surface. 
Immobilization of the ligand to the surface of the chip can be done by three different 
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approaches; direct coupling to the surface creating the covalent bond between 
molecules, non-covalent capture via a suitable additive molecule already coupled to the 
surface and hydrophobic adsorption with molecule of interest or hydrophobic carrier of 
lipid character. 
 
The sensor chip consists of glass support covered with a thin layer of gold - this creates 
the conditions to generate the SPR response - and on the gold layer there is some 
coating providing an environment to attach the ligand. The coating varies between 
different types of chips and also uncoated chip is available when users need to prepare 
their own surface for special applications. The sensor chip itself is mounted on a plastic 
carrier placed in the plastic sheath to facilitate handling. 
 
 Biacore provides a range of sensor chips; therefore the choice depends on the nature of 
molecule to be coupled and the requirements for the analysis. In this study we used the 
Sensor chip CM5, the most versatile chip available. It is suitable for ligand fishing and 
for high capacity capture; it supports a wide range of immobilization levels, attaches 
proteins, nucleic acids, carbohydrates or small molecules; carboxyl groups on the 




Fig.1 Simple illustration of the sensor chip surface (www.biacore.com) 
 
 A dextran matrix is used as the coating here. The dextran belongs to most common 
coatings of Biacore chips, but they are available with several the different properties. 
The dextran matrix is hydrophilic, flexible with low non-specific binding and high 
binding capacity. The matrix in CM5 is a carboxymethylated dextran covalently 
attached to the gold layer. The protein molecules to be studies are covalently coupled to 
the sensor surface via amine, thiol, aldehyde, hydroxy or carboxyl groups. High surface 
stability allows repeated analysis on the same surface. Analyte interactions with protein 
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are monitored by injecting samples over the prepared surface of a sensor chip.    
Between injections, the surface is regenerated by selective dissociation of the interaction 
partners. Regeneration solutions ensure complete dissociation, without affecting the 
binding characteristics of the immobilized partner. 
The surface concentration of the immobilized interaction partner varies according to the 
type of analysis. Generally concentration and specificity assays require a high surface 
concentration, while lower concentrations are preferable for kinetic analysis. 
 
  Closer view to each of the components 
 
  The gold layer 
 
The gold layer is uniform and app. 50 nm thick. It provides good conditions for surface 
plasmon resonance. It gives a well-defined reflectance minimum at easily handled 
visible light wavelengths, and it is also suitable to covalent bonding of dextran matrix 
layers at the same time as the metal is largely inert in physiological buffer conditions. 
 
  The dextran matrix 
 
A matrix of carboxymethylated dextran is covalently attached to the gold surface. This 
layer is approximately 100 nm thick. The dextran matrix close to the surface is 
equivalent in concentration to an aqueous solution of about 2% dextran and imparts 
these important properties: 
 It provides a hydrophilic environment favourable to most solution 
 It provides defined chemical basis to covalent coupling using a variety of 
chemical reactions  
 Flexibility, which allows relatively free movement of attached ligands 
 The negatively charged carboxyl groups allow electrostatic concentration of 
positively charged molecules from solution  that enable effective immobilization 






Optical system - SPR 
 
Biacore system uses surface plasmon resonance (SPR) to monitor biomolecular binding 
events in real time without the use of labels. The SPR is a phenomenon that occurs in 
thin conducting films at an interface between media of different refractive index. In 
Biacore systems, the media are the glass of the sensor chip and the sample solution; the 
conducting film is a thin layer of gold on the sensor chip surface. 
 
Molecules binding to the sensor surface cause changes in the refractive index close to 
the surface which are detected as changes in the SPR signal (expressed in resonance 
units, RU where one RU is equivalent to one picogram per square millimeter on the 
sensor surface). In general, the refractive index change for a given change of mass 
concentration at the surface layer is practically the same for all proteins and peptides, 
and is similar for glycoproteins, lipids and nucleic acids. 
 
Detection unit consists of an optical unit which includes light source and detector, the 
opto-interface and the removable sensor chip. Forming of each of the components is as 
follows. The glass side of the sensor chip is pressed into the contact with a glass prism 
in the optical unit. A silicone opto-interface is between the sensor chip and the prism, 
(matched in refractive index to the glass, ensures good optical coupling between the 
prism and the removable sensor chip.) 
 
 
Fig. 2 The scheme of detecting unit and SPR principle – BiacoreX-Handbook (www.biacore.com) 
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Light is directed at, and reflected from, the side of the surface not in contact with 
sample. SPR causes a reduction in the reflected light intensity at a specific combination 
of angle and wavelength. Light from a near-infrared light-emitting diode (LED) is 
focused through the prism on to the sensor surface in a wedge-shaped beam, giving a 
fixed range of incident light angles. Light reflected from the sensor chip is monitored by 
a linear array of light-sensitive diodes covering the range of incident light angles. The 
diodes are spaced with a resolution corresponding to approximately 0.1º, and computer 
interpolation algorithms determine the angle of minimum reflection (the SPR angle) to a 
high accuracy. 
 
Under conditions of total internal reflection, light incident on the reflecting interface 
leaks an electric field intensity called an evanescent wave field across the interface into 
the medium of lower refractive index, without actually losing net energy. The amplitude 
of the evanescent field wave decreases exponentially with distance from the surface, 
and the effective penetration depth in terms of sensitivity to refractive index is about 
20% of the wavelength of the incident light. 
 
 




At a certain combination of angle of incidence and energy (wavelength), the incident 
light excites plasmons (electron charge density waves) in the gold film. As a result, a 
characteristic absorption of energy via the evanescent wave field occurs and SPR is seen 
as a drop in the intensity of the reflected light. Because the evanescent wave field 
penetrates the solution, conditions for this resonance effect are very sensitive to the 
refractive index of the solution within the effective penetration depth of the evanescent 
field. Changes in solute concentration at the surface of the sensor chip cause changes in 
the SPR conditions. The penetration depth of the evanescent wave determines the 
thickness of the solution layer where refractive index changes are monitored: only 
refractive index changes close to the surface affect the SPR signal. 
 
 SPR arises in principle in any thin conducting film under the conditions described, 
although the wavelength at which resonance occurs and the shape of the energy 
absorption profile differ with different conducting materials. Gold is used in Biacore 
sensor chips because it combines favorable SPR characteristics with stability and a high 
level of inertness in biomolecular interaction contexts. Biomolecular binding events 
cause further changes in the refractive index and the SPR signal. Biacore X precisely 
controls every critical step to detect the small changes between a baseline signal and the 
signal generated when a second or third molecule interacts. 
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 1.2. PURINE NUCLEOSIDE PHOSPHORYLASE 
 
Purine nucleoside phosphorylase (PNP) is an enzyme, which catalyzes the cleavage of 
the glycosidic bond between oxygen and nitrogen in both purine ribonucleosides and 
deoxyribonucleosides. The presence of inorganic orthophosphate is needed as a second 
substrate. This reaction is for the natural substrates reversible. 
 
 β-purine nucleoside + Pi ↔ purine base + α-D-pentose-1-phosphate 
 
Under in vivo conditions phosphorolysis is highly favoured over synthesis, due to 
coupling with two additional enzymatic reactions, oxidation and phosphoribosylation of 
the liberated purine bases by xanthine oxidase (Xox) and hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT), respectively. The role in purine metabolism is in 
the salvage pathway. PNP enables the cells to utilize purine bases from metabolized 
purine ribo- and deoxyribonucleosides to synthetize purine nucleotides. [1] 
  
 PNP belongs to a class of N-ribohydrolases and transferases, where the transition states 
share ribosyl oxocarbenium-ion character, in which cleavage of C-N glycosidic bond 
occurs by an SN1-like mechanism. 
 
 DISTRIBUTION IN NATURE 
 
Various PNPases are widely distributed in the nature. PNP is a ubiquitous enzyme 
distributed in number of tissues and cells in mammals, birds, fish, yeast and several 
species of bacteria.
 
[2] However, the enzyme activity differs both in each organism and 
each tissue or cell type. The highest activities in humans are found in kidneys, 
peripheral lymphocytes as well as in red cells or in granulocytes. According to volume, 
red cells are the richest source of PNP. On the other hand, erythrocyte PNP levels in 








ROLE IN METABOLISM  
 
In intact cells, PNP functions in direction of phosphorolysis, leading to degradation of 
purine nucleosides via coupling with guanase and Xox. It was found, that histochemical 
localization of PNP in rat and human liver cells is similar to that of Xox, which converts 
Hx to urate via xanthine. [1] PNP functions principally in the direction of breakdown of 
guanine or hypoxanthine ribo- and deoxyribonucleosides. Adenosine and 
deoxyadenosine have, in addition to PNP, a specific kinase, which is unreactive with 
nucleosides of guanine or hypoxanthine. Also, the enzyme, adenosine deaminase, is 
found in a number of mammalian tissues. This enzyme catalyzes the deamination of 
adenosine/deoxyadenosine to inosine/deoxyinosine, which are latter substrates for PNP. 
PNP can also be a salvaging enzyme for ribose and deoxyribose moieties of 
nucleosides. α-D-ribose-1-phosphate (R-1-P) can be converted by phosphoribomutase to 
ribose-5-phosphate, a precursor of 5-phosphoribosyl-1-pyrophosphate (PRPP), a co-





Fig. 4 Metabolic scheme; Bzowska et al. (2000) [1] 
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 ROLE IN CHEMOTHERAPY 
 
 PNP can play a role in chemotherapy in these ways: 
 catalyzing the breakdown of nucleosides containing purine analogs, which may 
be of anticancer or antiviral activity 
 promoting the incorporation of purine/pyrimidine analogues into the nucleotides, 
nucleic acids by increasing intracellular pools of R-1-P or dR-1-P [2] 
 On the other hand, PNP deficiency is an inherited disease of purine metabolism, 
leading to T-cell immune deficiency, whereas B-cell function remains normal. Thus 
potent inhibitors of human PNP are potential selective immunosuppressive agents. 
 Moreover, many purine nucleoside analogues with potential chemotherapeutic activity 
are inactivated by cellular PNP before reaching their target cells. Therefore potent 
selective PNP inhibitors are considered useful to enhance chemotherapy, e.g. with 2′3′-
dideoxyadenosine (with anti-HIV activity) which is a substrate for human PNP, or 2-
chloro-2′-deoxyadenosine (anti-hairy-cell leukemia drug). The latter can not be applied 
orally since it is inactivated by PNP of enteric bacteria. [5] 
 
 MOLECULAR PROPERTIES 
 
According to protein structure, there are two main classes of, which have been 
characterized. The so called "low molecular mass" phosphorylases are trimeric enzymes 
(Mr about 90 kDa) specific for 6-oxopurine nucleosides, often referred to "Ino-Guo 
phosphorylases" and found mainly, but not exclusively, in mammals (e.g. human, 
calf...). The second group, so-called "high molecular mass" phosphorylases (Mr in range 
110-160kDa) are hexameric and found in microorganisms. Their specificity is broader; 
both 6-oxo and 6-aminopurine nucleosides serve as a substrate. This class includes the 
enzymes from E. coli, Salmonella typhimurium, Klebsiella and Sulfolobus solfataricus. 
[1] 
This categorisation seems to be very simple, but in fact there are a number of deviations 
from these two classes. It depends on method used for determination of the structure. 
There are many reports describing PNPs from both bacterial and mammalian sources 
with subunit compositions other than trimers or hexamers. It is usually difficult, for 
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example, to distinguish between pentamer and hexamer with experimental data of 125 
kDa for Mr, when a subunit mass is 24 or 25 kDa. [1] 
 
  PHYSICO-CHEMICAL PROPERTIES 
   
  pH 
  
 All PNPs, with very few exceptions, show broad pH activity optima between pH 7 and 
8, or even 6 and 8.5, depending on the source of enzyme. The most striking exceptions 
are PNP I and PNP II from Bacillus stearothermophilus (pH neutral and pH 11) or 
Brevibacterium acetylicum (pH 8.5) On the other hand, acidic pH is optimum for 
xanthosine phosphorylase from E. coli or PNP from chicken liver (pH 6). Activity 
optima for E. coli and calf spleen PNPs correspond to the pH-dependent stability 
profiles of these enzymes. In general, high molecular mass PNPs are more thermostable 
than low molecular mass ones. [1]  
 
 Isoelectric point 
 
Isoelectric points are in pH range from 4.2 (PNP from human mitochondria) to 6.8 
(PNP from Plasmodium lophurae). Isoelectric point is important fact in kinetic 
behaviour of PNPs. Human PNPs of different tissues show electrophoretic 
heterogeneity resulting from post-translational modifications, but in contrast, calf spleen 




 Absorption in the UV is typical for most proteins, with absorption maxima at 278 - 280 
nm. Considerable difference occurs in extinction coefficients of various PNPs, since 
some of them do not contain tryptophan residues in amino acid sequence. E.g. human 
erythrocyte and calf spleen PNPs are ε %1
1cm
= 9.6 and E. coli and Cellulomonas PNPs have 
extinction coefficients of ε %1
1cm
= 2.7 and 5.9, respectively. 
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Fluorescence emission spectra of E. coli (contains only tyrosine) and calf spleen 
enzymes (contain both tyrosine and tryptophan) show their maxima at 304 and 340 nm, 
respectively. These spectra were obtained from interaction studies of enzyme with 
substrates or inhibitors in solutions. [1] 
 
 SPECIFICITY  
 
Natural substrates 
 The natural substrates of low molecular mass PNPs, as has been mentioned, are 6-
oxopurines (guanine, hypoxanthine and xanthine) and their ribosides and 2´-
deoxyribosides, whereas the high molecular mass enzymes additionally accept 6-
aminopurine (adenine) and its nucleosides. Ado or/and Ade can also react with low-mm 
enzymes in phosphorolysis or/and synthesis like competitive inhibitors. This was 
observed at PNPs from Sarcoma 180 cells, Proteus vulgaris, or Cellulomonas. [1] It 
appears that adenine may bind with some mammalian PNPs, but however, reaction 
velocities are so low, that it is unlikely that PNP plays significant role in adenine 
metabolism in mammalian cells. [2] Several enzymes exhibiting stricter specificity to 6-
aminopurine nucleosides were found and they are referred to as adenine nucleoside 
phosphorylases or Ado phosphorylases.  
 
PNP from E. coli cells cultivated in the presence of xanthosine is homohexamer with 
specificity and sequence of the low-mm enzymes, but it accepts xanthosine as a 
substrate. Xao, with pKa~5.7 occurs in physiological pH as a monoanion, resulting from 
dissociation of N(3)-H bond, and remains still 6-oxopurine. But its mode of binding 
probably differs from that of neutral nucleoside. [1]  
 
Analogues 
 Early studies (70´s-80´s) described the specificity of low-mm mammalian PNPs and 
also high-mm enzymes from E. coli and Salmonella typhimurium versus a variety of 
nucleosides analogues with structural differences in the purine base or/and sugar 
moiety. Subsequently, comparison of the enzymes from E. coli and mammalian sources 
(calf and human) revealed the existence of nucleoside analogues that are selective 
substrates only for E. coli PNP. These include 1-methylinosine, 1-methylguanosine,  
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In a study with PNP isolated from vegetative cells and spores of Bacillus cereus, no 
differences in substrate specificity were seen. The analogue, 6-mercaptopurine 
ribonucleoside, was active as a substrate, whereas 2,6-diaminopurine ribonucleoside had 
a little or no activity.[2] 
 
 Unusual substrates 





and others are substrates of PNPs from various sources, and undergo nonreversible 
phosphorolysis, or have a Keq so small that the reaction is essentially irreversible. Others 
are resistant to phosphorolysis, but their bases may be substrates in the reverse, 
synthetic pathway, e.g. allopurinol, 8-azapurines.  
 Although Ado is not a substrate of low-mm PNPs, m
7
Ado and 3-β-Ado are substrates 
with a Vmax almost twice that for Ino with the calf spleen enzyme. N(7) methyl 
analogues of Ino and Guo are excellent substrates, as are other 7-alkylguanosines, such 
as, ethyl, propyl, butyl, benzyl.[1] 
 
Carbohydrates 
The sugar moiety of purine nucleosides have 1-carbon bounded to 9-nitrogen of the 
purine ring in the β configuration.[2] Both low-mm and high-mm PNPs are able to 
cleave the glycosidic bond of purine nucleosides, with the pentosyl moiety attached not 
only at position N(9), but also at N(3) or N(7). [1] 
 
PNPs react with both ribonucleosides and deoxyribonucleosides, although in some cases 
with different kinetic parameters. In testing activity of a variety of nucleoside analogues 
modified in the sugar moieties, it was observed that arabinose-1-phosphate could not 
replace R-1-P as a substrate for fish muscle PNP and the carbocyclic analogue of inosin, 
where oxygen of the furanose ring is replaced by methylene group, did not react with or 
inhibit PNP from H. Ep No.2 cells. [2] 
 
Reaction catalyzed 
 It is well established that PNPs can catalyze these reactions: 
 Reversible phosphorolysis:  
                            purine riboside + phosphate ↔ purine + ribose-1-phosphate 
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 Irreversible arsenolysis:   
                            purine riboside + arsenate → purine + ribose + arsenate 
Pentosyl transfer: 










 With natural substrates and some nucleoside analogues, where phosphorolysis is 
reversible, the equilibrium is thermodynamically in favour of nucleoside synthesis. 
With the human erythrocyte enzyme, and those from calf spleen and E. coli, the 
equilibrium constant (Keq) is ~ 50. But in vivo, phosphorolysis is the predominant 
reaction, due to coupling with other enzymes.  Most of the unusual substrates of PNPs 
undergo phosphorolysis/synthesis irreversibly, or with Keq so small that the reaction is 
irreversible. [1] 
 
When inorganic phosphate is replaced by arsenate, reversible phosphorolysis catalyzed 
by PNP becomes irreversible arsenolysis. [1] Arsenolysis leads to formation of a highly 
unstable intermediate, ribose-1-arsenate, that hydrolyses immediately upon formation to 
yield ribose and arsenate. [2] 
  
Direct transfer of the ribose or deoxyribose moieties without the intermediary formation 
of a phosphorylated pentose is probably an overall result of both phosphorolysis and 
synthesis, directed in part by the relative affinities for the enzyme of two purine bases. 
Stereochemical considerations make direct transfer reactions unlikely. Several studies 
indicate that the reaction mechanism is sequential rather than Ping-pong. Attempts to 
demonstrate and isolate ribosylated intermediate were unsuccessful. [1, 2] 
   
 KINETIC PROPERTIES  
 
 Kinetics 
 Kinetic studies have been performed in many different laboratories and Km values even 
for the same enzyme markedly differ from one to another. For example, the Km for 
inosine with human erythrocytic PNPase has been reported at values ranging from 
0.05 mM to 1 mM. It may be due to several influences; method of assay, method of 
separation and purification of enzyme, phenomenon of "substrate activation at high 
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substrate concentration"[1], whereas at low concentration the substrate activation is not 
apparent. A possible explanation is that a substrate activation results from a cooperative 
effect among enzymic subunits, wherein it is assumed that the enzyme has two catalytic 
sites that interact with each other. [2] 
 The low and high-molecular mass phosphorylases share one important property: they 
show non-Michaelis kinetics with one or more substrates. Such data are consistent with 
substrate-induced cooperativity. It is interesting that the Km values for orthophospate are 
relatively similar and fall in the range of 0,3 to 1,5 x 10
-3
 M [2] 
 
Table 1Kinetic constants for phosphorolytic and synthetic pathways of the reaction catalyzed by 
PNP from various sources [1] 
Kinetics constants determined by fitting classical Michaelis-Menten kinetic equations: 
PNP 
Variable substrate and its 
concentration range (mM) 
Km (μM) 
E. coli Pi   0.1 – 0.5 120 
Ino 0.01 – 0.5 32 
Ino   nd 47 
Guo 0.01 – 0.1 ~20 
Ado nd 12 
R-1-P nd 40 
dR-1-P nd 100 
Human erythrocytes Ino nd 45 
Ino 0.01 – 0.5 ~28 
Guo nd 12 
Ado nd 650 
Pi 0.08 – 0.25 66 
Pi 0.25 – 2 423 
Calf spleen Ino 0.01 – 0.5 13 
Guo 0.01 – 0.1 11 




The catalytic mechanism has been well studied; the cleavage reaction is believed to 
proceed through an SN1 mechanism with oxocarbenium nucleoside intermediate, with 
ordered substrate binding, and with product release as the rate-limiting step.  
 Although the active site residues of trimeric and hexameric PNPs show considerable 
differences, the mechanisms are thought to be similar, with kinetic isotope effects 




 Escherichia coli PNP 
 
E. coli PNP is the most studied enzyme from the group of high molecular mass PNPs. 
Typical representative is the product of deoD gene, referred to as E.coli PNP-I. It has 
been found that incubation of E. coli in the presence of xanthosine (Xao, but no other 
base or nucleoside) leads to the appearance of a second enzyme. This enzyme is a 
product of an induced xapA gene and cleaves more efficiently 6-oxopurine nucleosides 
like Xao, Guo and Ino, but not Ado. In the literature, it has been variously referred to as 
xanthosine phosphorylase, inosine-guanosine phosphorylase or E. coli PNP-II. Here the 
latter is used. 
 
 SUBSTRATE SPECIFICITY 
 
The nucleobase specificity depends on the source, from which the enzyme is isolated. 
Whereas the human enzyme is specific for 6-oxopurine ribo- and deoxyribonucleosides, 
the Escherichia coli enzyme PNP-I accepts additional substrates including both 6-oxo- 
and 6-aminopurine ribo- and deoxyribonucleosides, and it even cleaves Adenosine 
(Ado) more effectively than Ino and Guo. On the other hand, E. coli PNP-II is unable to 
accept Ado, whereas Xao is an excellent substrate. The substrate specificity of this 
xanthosine-induced enzyme differs from that of E. coli PNP-I. PNP-II does not cleave 
or synthetise Ado or dAdo, but catalyzes the phosphorolysis of Xao, Ino and Guo. Thus, 
the specificity of this xapA-encoded PNP appears to be closer to that of mammalian 
PNP than to that of E. coli deoD encoded PNP. [3, 4, 5] 
 
Substrate specificity in sugar moiety is similar in both E. coli PNPs. Both enzymes 
cleave ribonucleosides, 2´-deoxy-, 5´-deoxy-, and 2´,3´-dideoxyribonucleosides. 
However, a significant difference is that PNP-II fails to bind or cleave purine 









PNP-I is a homohexamer in crystal form, but its subunit composition in solution has 
obviously not been established. PNP-II also appears to be a homohexamer, but with 
some evidence of co-existence of a trimeric form. PNP-II subunit arrangement is 
qualitatively different from the “trimer of dimers” arrangement of PNP-I; it is better 
described as “dimer of trimers”. [4] The hexamer may be regarded as a flat cylinder 
approximately 60 Å thick and a diameter of 100 Å. In the centre of the hexamer there is 
a channel of approximately 20 Å diameter, filled with 24 water molecules. The distance 
between the active centres of dimers is about 19 Å. A comprehensive view of the 
hexamer indicates, that the overall structure is better described as a trimer of dimers. [5] 
The monomers alternate in an up/down fashion around the disc, with three of the active 
sites near the top and three near the bottom. The structures of the three 
crystallographically independent monomers vary slightly within the hexamer and from 




Fig. 5 Structure of the E. coli PNP hexamer. Three of the six monomers are crystallographically 
independent. The A, B and C monomers are generated from the A´, B´ and C´ monomers by 




 CATALYTIC SITES 
 
The core of each monomer consists of a nine-stranded mixed β-barrel, and is 
surrounded by eight α-helices, also found in mammalian PNPs, although there is no 
sequence homology between E. coli and mammalian enzymes. The active centre is 
located on the surface of each monomer and is exposed to solvent. It is composed of 
residues belonging to two neighbouring subunits [5] and consists of phosphate-binding 
site, ribose-binding site and purine-binding site. 
 
 Phosphate-binding site 
The phosphate binding site is positively charged by three arginine side-chains and is the 





, Ser90 N, Ser90 O
γ
 and Arg43 N
η 
from the adjacent monomer. All 
phosphate atoms form at least two hydrogen bonds or salt bridges with protein. The 
phosphate anion in monomers B or C has in principle similar contacts with the protein 
as in monomer A. Kinetic data show cooperative binding of phosphate to E. coli PNP, 
but since only one anion per monomer was found in the crystal structure, it supports the 
hypothesis, that there are two conformations of the enzyme with different affinities for 
phosphate. Because the phosphate binding site consists of residues belonging to two 
monomers forming a dimer, it is likely that binding of phosphate to one monomer 
affects conformation of the second monomer of the dimer, and thus the affinity to 
phosphate. [5] 
 
 Ribose-binding site  
The ribose binding site is located very close to the position of phosphate anion, and all 
sugar oxygen atoms have direct contacts with it, except for O5´. The ribose binding site 






. Ribose O5´ forms a hydrogen 
bond with His4 N
ε
 of the adjacent monomer and oxygens O3´ and O4´ are bridged by 
Glu181 O
ε
 and Ser90 O
γ
, respectively. The latter is not observed in monomers B and C. 
[5] The 3´-hydroxyl group of 2´-deoxy ligands can interact with both carboxylate 
oxygen atoms, or maintain only the usual single (but stronger) hydrogen bond. Similar 
B-factors were observed for both compounds, and the Km value for F-Ado was only 
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marginally lower than for F-dAdo. This suggests that loss of the O2´-hydroxyl group in 
ribose may not significantly affect substrate binding. [3] 
 
 Purine-binding site 
The purine binding
 














 and it 
is largely exposed to solvent. The first four of these residues form a hydrophobic
 
pocket 




 are located between the
 
purine base and the 




an angle of 60° with the plane of the 
purine ring. [3] 
 
A network of water molecules is observed, starting at the ring atom N(1) of the base and 
the exocyclic O(6). In addition, there is an ansembly of π-interactions between the base, 
Phe159 and Tyr160, which contribute to stabilization of peptide tertiary and quaternary 
structures. All interactions in the base binding site are unspecific, which explain the 
observed broad specificity of PNP of E. coli towards purines. For example, E. coli PNP 
is able to bind the purine riboside that has no hydrogen bonding substituents at the 
purine ring, as well as the riboside of benzimidazole, which lacks nitrogen atoms at 
positions N(1) and N(3). This supports the observation that aromatic-aromatic 
interactions with Phe159/Tyr160 direct the base into its binding position. [5] 
 





 to purine N7. As the glycosidic bond begins
 
to cleave, the resulting 
oxocarbenium ion is probably stabilized
 
by the negatively charged phosphate group, 
since no amino acid
 
side chain is available for this purpose. The reaction is
 
completed 
by bond formation when the phosphate ion captures
 
the oxocarbenium intermediate. [3] 
 
 ROLE IN CHEMOTHERAPY 
 
The differences in substrate specificity between the hexameric and trimeric PNPs 
suggest a strategy for anticancer suicide gene therapy in which nontoxic nucleoside 
prodrugs are cleaved to cytotoxic purine analogues. [3] In vitro studies showed that 
melanoma cells transfected with the E. coli PNP gene convert non-toxic 6-methylpurine 
riboside into the highly cytotoxic purine base, which, as a membrane permeable agent, 
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mediates effective killing of neighbouring cells. [5] To optimize PNP anticancer gene 
therapy, the prodrug should be completely inert with respect to human enzymes and 
efficiently cleaved only by tumour cells expressing E. coli PNP. [3] 
 
1.3. THYMIDINE PHOSPHORYLASE 
 
Thymidine phosphorylase (TP) is an enzyme, catalyzing the phosphorolysis of 2´-
deoxypyrimidine nucleosides. TP belongs to a family of N-ribosyl phosphorylases, but 
it is highly specific for the 2´-deoxyribonucleosides of thymine and related pyrimidine 
bases, whereas uridine phosphorylase (UP) doesn't distinguish between ribose and 
deoxyribose in pyrimidine nucleosides. [8, 7] TP catalyzes the reversible 
phosphorolysis of thymidine as follows: 
 
 thymidine + phosphate ↔ 2-deoxyribose-1-phosphate + thymine 
 
Although the reaction is reversible, nucleic acid homoeostasis is dependent upon the 
catabolic reaction which drives the salvage pathway. The salvage pathway ensures that 









Fig. 6 TP catalyses the breakdown of thymidine to the base thymine and the sugar 2-deoxy-D-
ribose-1-phosphate. The latter can only leave the cell once it has been dephosphorylated. TP clears 
cytostatic thymidine from cytoplasm and drives the nucleoside salvage pathway. 
 
 DISTRIBUTION IN NATURE 
 
 Thymidine phosphorylase is of widespread occurrence in microorganisms. [9] 
 In the 1970s TP was purified from both Escherichia coli and Salmonella typhimurium. 
In 1980s, a molecule extracted from human platelets was seen to have angiogenic 
effects and became known as platelet-derived endothelial-cell growth factor (PD-
ECGF). Later, the angiogenic activity of 2-deoxy-D-ribose, a thymidine metabolite, was 
also reported. Subsequently, PD-ECGF and TP were confirmed as the same molecule. 
[6] The sequencing of PD-ECGF by Moghaddam and Bicknell revealed that PD-ECGF 
is the enzyme TP. [7] 
 
 THE ROLE IN HUMAN ORGANS, TISSUES AND METABOLISM 
 
Angiogenesis is the term used to describe the formation of new blood vessels from the 
existing vasculature. In order to attract new vessels, a tissue must release an endothelial-
cell chemoattractant. 2-deoxy-D-ribose is produced in vivo by the catalytic action of 
thymidine phosphorylase (TP) on thymidine (according to scheme above) and has 
recently been identified as an endothelial-cell chemoattractant and angiogenesis-
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inducing factor. 2-deoxy-D-ribose appears to lack a cell-surface receptor, which is in 
contrast to majority of known endothelial-cell chemoattractants (mostly polypeptides) 
that bind to endothelial-cell-surface receptors.  
 
 TP expression is elevated in many solid tumours and in chronically inflamed tissues, 
both known areas of active angiogenesis. TP levels are higher in rheumatoid arthritis, in 
psoriatic lesions and lesser in osteoarthritis. High TP levels were found at the edge of 
gastric ulcers - a site of chronic inflammation which contains the highest concentration 
of inflammatory cells. A tumour is also a site of chronic inflammation. In some cancers, 
the invading macrophages can overexpress TP, but not the tumour cells themselves. TP 
levels in macrophages that have invaded colon tumours correlate well with microvessel 
density and are a good prognostic indicator. 
 
There is evidence that TP is also involved in physiological angiogenesis such as 
endometrial angiogenesis during the menstrual cycle. The endometrium undergoes 
extensive angiogenesis during each menstrual cycle. TP is the only angiogenic factor 
whose levels have been shown to vary during the course of the menstrual cycle. The TP 
promoter contains half-palindromic estrogen response motifs, and endometrial TP 
expression is raised by the unique combination of progesterone and transforming 
growth factor-b1. [10] 
 
TP expression is frequently raised in a wide range of human cancer tissues. [6] 
However, immunohistochemistry revealed that the cell type expressing TP varied 
between tumors. Thus, in some tumors, expression was restricted to the neoplastic 
element and in others it was restricted to the stromal or inflammatory component. [10] 
 Expression is tumour dependent, and depends on the presence of other nucleoside 
metabolism enzyme such as thymidylate synthase. 
 
Thymidine phosphorylase also acts as an antiapoptosis factor. Because TP expression is 
very low in healthy human tissues, overexpression has been associated with the 
promotion of the tumour-genesis, whereas its genetic or pharmacological inhibition 
might suppress tumour progression. TP was shown to be associated with the anti-
apoptosis mechanism, especially in cells damaged by stress, caused by factors such as 
hypoxia or chemotherapeutic drugs. [6] 
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ROLE IN CHEMOTHERAPY 
 
 Of the many nucleoside metabolism enzymes, TP is unique because it can both induce 
angiogenesis and protect cells from apoptosis. TP expression is stimulated by various 
types of anticancer treatments such as chemotherapy (taxanes, cyclophosphamide, 
oxaloplatine) or radiotherapy. Suppression of TP may slow down or suppress the 
recovery of cancer cells. Potential inhibitors of this enzyme could be useful in a 
treatment of some tumours, because they depend on the nucleotide salvage pathway for 
their proliferation. Also involvement in the phosphorolysis of different pyrimidine 
nucleoside analogues that can be used as antiviral or anticancer agents makes this 
enzyme interesting as a therapeutic target. 
 The best combination between TP-targeting therapies and TP-inducible treatments 





TP is a dimer made up of two identical subunits with a dimeric molecular mass ranging 
from 90 kDa in Escherichia coli to 110 kDa in mammals. E. coli subunit is about 45 
kDa and eukaryotic TP subunit normally has a molecular mass of 47 kDa. Human TP 
shares 39% of sequence identity with E. coli. [10] 
 
 BINDING SITES 
 
Each subunit appears as a large α/β domain and a smaller α domain separated by a cleft. 
The phosphate ion is bound in the phosphate binding site in the α/β domain where it is 
stabilized by a salt bridge with Lys-84 and several hydrogen bonds with backbone 
amide nitrogens and hydroxyl groups from residues lining this pocket. The thymine 
base is bound in the thymidine binding site that is present in the α-domain, and its O4, 
N3, and O2 atoms are engaged in direct interactions with Arg-171, Ser-186, and Lys-
190, respectively. There exist two forms of active site; open and closed, which are 
 29 
separated by low-energy barrier. To generate a catalytically competent active site a 
domain closure is necessary. In this hinge-based closing motion there play roles Cα 
atoms of residues Leu-117 and Arg-171, which are placed in different domains.[8] 
 
 CATALYTIC MECHANISM 
 
There are two studies, which deal with investigating of reaction mechanism of TP 
phosphorolysis using computer modelling. Each of them uses different program and 
method for observation and their results are in disagreement.  
The study of Mendieta et al. [8] used molecular dynamics simulation and quantum 
mechanical calculation to find out the role of Histidine-85 in catalytic mechanism. They 
examined that His-85 can be involved in the transfer of the proton from the phosphate to 
the O2 thymine and also that the enol form of the free base is the most likely 
intermediate product, which then spontaneously tautomerize to a more stable keto form. 
They describe the whole process as two step mechanism. The first step is slower and 
rate limiting, during which the imidazol ring of protonated His-85 interacts with O2 in 
thymidine to make it a better leaving group. Weakening of the glycosidic bond 
generates an intermediate oxycarbocation in the sugar.  The second step is a fast 
reaction between oxycarbocation and phosphate dianion, which acts as a nucleophile. 
These results support an SN1 mechanism for the phosphorolysis reaction. [8] 
 On the other hand, the study of Birck and Schramm [7] also dealing with observations 
of transition state of TP enzyme using kinetic isotope effect analysis followed by 
computer modelling reveals, that human thymidine phosphorylase proceeds through an 
SN2-like mechanism. The pKa of the 2-carbonyl oxygen of thymine is -2.98
 
which 
suggest that, at physiological pH, it is difficult to protonate this position to activate the 
leaving group. In TP, the activation of leaving group requires a higher degree of 
nucleophile participation for the reaction to proceed. [7] 
 
1.4 USE OF ENZYMES AS BIOCATALYSTS 
 
Purine nucleoside phosphorylase and also thymidine phosphorylase obtained from 
strains of E. coli may be used as a tool for enzymatic synthesis of nucleoside analogues 
with potential antiviral or antineoplastic activities. This applies particularly to those 
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instances where chemical synthetic procedures are tedious and inefficient. These 
procedures are useful for preparation of labelled nucleosides when the labelled purine is 
commercially available, but its desired nucleoside is not. 
 
The general procedure for such syntheses involves the use of a pyrimidine nucleoside 
phosphorylase (uridine or thymidine phosphorylase) to release the α-D-pentose-1-
phosphate from uridine or thymidine, which is then coupled by PNP to the desired 
purine base to give a purine nucleoside. Depending on enzyme specificity, the pentose 
ring may be ribose, 2´-deoxyribose, 2´,3´-dideoxyribose, arabinose or some other 
pentose. The entire reaction sequence is conducted in a single vessel, a so called “one-
pot” synthesis. Although the kinetics of reverse synthetic reaction by PNP has been 
much less extensively investigated than the kinetics of phosphorolysis, the reverse 
pathway has been widely exploited for this purpose.  
 
There exists studies, where PNP and TP enzymes from E. coli were employed for the 
synthesis of 6-dimethylamino-9-(β- D-deoxyribofuranosyl)-purine and 2-amino-6-
chloro-9-β-D-ribofuranosylpurine each in 80% yield. A subsequent illustration of 
foregoing procedure is from the same laboratory. The α-D-2´,3´-dideoxyR-1-P, 
generated from 3´-deoxythymidine by TP from E. coli, was coupled to the desired 6-
alkoxypurine by PNP (also E. coli). 
 
TP and PNP were also employed in experiments of trans-5´-deoxyribosylation by PNP. 
The enzymes were used for the synthesis of the 5´-deoxy analogues of 6-thioguanosine 
and 6-merkaptopurine riboside, as well as the corresponding 2´,5´-dideoxy congeners, 
in yields of 40-50%. 
 
An interesting variant of the general procedure, using only one phosphorylase, was 




Ino are excellent substrates for PNP from E. coli. 




Hx do not markedly inhibit phosphorolysis, 





Ino) as the ribose phosphate donor, the desired purine base 
acceptor, and only PNP, which generated R-1-P from m
7
Guo and coupled it to the 
desired purine. Three known nucleosides were synthesized in this manner in the yields 
of 60-100%. [1] 
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 2. EXPERIMENTAL PART 
 
2.1. AIMS OF THE STUDY 
   
This work largely deals with two enzymes; Purine nucleoside phosphorylase (PNP) and 
Thymidine phosphorylase (TP). It mostly concentrates on initial evaluation of Biacore 
SPR analysis for enzyme-substrate interactions of the enzymes.  
 
The first goal of the study was to test, if and how the enzymes produced by recombinant 
DNA technology can be bound on the carboxyl group containing CM 5 analytical chip 
of Biacore.  
 
Secondly, it was studied, how and on which conditions the enzymes on chips bind with 
their natural substrates. The conditions varied were temperature, buffer, pH, molarity, 
and flow rate in the chip cell.  
 
As natural substrates for PNP enzyme we used guanosine for the cleavage-directed and 
guanine with ribose-1-phosphate or deoxyribose-1-phosphate for the synthesis-directed 
reaction. For the TP enzyme, only the direction of phosphorolysis was studied, and in 
this its natural substrates thymidine, uridine and deoxyuridine were included. The whole 
reaction process took place in a Biacore X instrument.  
 
The stability of an enzyme-coated chip was also evaluated by repeating the TP substrate 





2.2.1   Chemicals supplied by Biacore 
 
Acetate buffer, pH 4.5 
10mM Sodium acetate 
Biacore AB, Sweden 
Acetate buffer, pH 5.0 
10mM Sodium acetate 
Biacore AB, Sweden 
EDC solution Biacore AB, Sweden 
Ethanolamine-HCl, pH 8.5 
1.0 M solution 
Biacore, Made in Scotland 
Glycine-HCl, pH 2.5 
10mM solution 
Biacore, AB, Sweden 
HBS-EP buffer, ready-to-use 
0.01M HEPES, pH 7.4 
0.15M NaCl 
3mM EDTA 
0.005% surfactant P 20 
Biacore AB, Sweden 
NHS solution Biacore AB, Sweden 
Mainatence Kit Biacore AB, Sweden 
 




Sigma Chemical, USA 
Acetic acid 99,8%  Riedel-de Haën, Germany 
Deoxyuridine Tintagel Limited, Hong Kong 
D-ribose-1-phosphate  
Bis(cyclohexylamine) salt 
(Fluka) Sigma-Aldrich, Canada 
Guanine Sigma Chemical, USA 
Guanosine Tintagel Limited, Hong Kong 
PNP from Prof. Miroshnikov, Inst. Mol. 
Biol., Sci. Acad. Russia, Moscow 
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Potassium dihydrogen phosphate MERCK, Germany 
Potassium dihydrogen phosphate MERCK, Germany 
Sodium acetate MERCK, Germany 
TP from Prof. Miroshnikov, Inst. Mol. 
Biol., Sci. Acad. Russia, Moscow 
Uridine Tintagel Limited, Hong Kong 
β-thymidine Tintagel Limited, Hong Kong 
 
2.2.3   Equipment 
 
Biacore X, USA 




2.3. METHODS  
  
2.3.1 THEORY 
Immobilization procedure - amine coupling 
 
The main steps for immobilization are generally the same. Immobilization of ligand to 
the sensor surface involves these three steps: 
 
 1. Activation of the sensor surface by appropriate reagents 
 2. Injection of ligand solution 
 3. Injection of reagent to deactivate remaining active groups and to remove non-




This immobilization method is based on a reaction between amino and carboxyl groups. 
Dextran layer of the sensor chip provides carboxyl groups and the ligand must carry 
amino groups. 
 
Fig. 6 Activation of the sensor surface by mixture of EDC/NHS – SensorSurface-Handbook 
(www.biacore.com) 
 
 At first, dextran surface is activated by mixture of 0,4M 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and 0,1M N-hydroxysuccimide (NHS) to 
give reactive succinimide esters. Then a ligand is passed over the surface and esters 
react spontaneously with primary amino groups or nucleophilic groups of ligand. The 
ligand is now covalently bound to the dextran matrix. The last step involves injection of 
1M ethanolamine-HCl pH 8 to deactivate remaining active esters. 
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Fig. 7 Amine coupling of the ligand to the sensor surface - SensorSurface-Handbook 
(www.biacore.com) 
 
Conditions for immobilization 
 Commonly used concentration of ligand is among 20-200 μg/ml. To get the high 
needed on the surface, a mechanism of electrostatic attraction of the ligand to the 
surface is necessary. Without this, the expected level of immobilization would be lower. 
This attraction is called as a pre-concentration and can increase the concentration of 
ligand on the sensor surface thousand-folds. 
This pre-concentration is achieved by using appropriate pH environment. The 
carboxymethylated dextran matrix of the sensor chip carries a negative charged net at 
pH values above app. 3,5. The pH of the immobilization buffer should therefore be 
higher than this and lower than isoelectric point of the ligand. 
 
 






The binding capacity of the surface depends on the level of immobilized ligand and it 
could be described in terms of the response at saturation as maximum response (Rmax). 
A theoretical value of Rmax can be calculated using the following formula, but usually 
experimentally derived Rmax is lower for the same reaction. It may be caused by the fact 





* immobilized amount * stoichiometric ratio  
 
But requirements of Rmax differ from purposes of analysis. A low Rmax is often 





 Biacore X enables different types of assays. They can be divided into two main groups: 
Direct binding assays and Indirect assays. Direct assays involve the simple binding of 
analyte from the sample to the ligand immobilized onto the surface of the sensor chip, 
and this type was used in the present study. The indirect binding of analyte involves the 
use of an enhancement molecule and results in a sandwich approach. 
The indirect assays can be further divided to Inhibition assay (solution competition) and 
Surface competition assay. 
 
 Interaction analysis is the process involving binding of analyte to the ligand and 
subsequent dissociation of analyte/ligand complex. Analyte is bound to the ligand 
during the injection and it is monitored in real time on the screen. After the analyte 
injection, when buffer flows over the surface, the dissociation of the analyte/ligand 
complex is monitored.  
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Fig. 9 Simple scheme of interaction analysis sensorgram – www.biacore.com 
 
 During the injection of a sample, when buffer environment greatly differs from the 
running buffer, a bulk effect on refractive index occurs, but it doesn‟t affect the binding. 
If the sample is diluted in the running buffer, this bulk shift is minimized. Role of the 
reference cell is central in correcting the result of an analysis for this bulk effect. The 
bulk contribution is subtracted from the analytical reflectance as illustrated in Fig. 10. 
The Biacore X Control Software can automatically subtract the bulk contribution. 
 
 
Fig. 10 The effect of reference subtraction – Biacore X; Getting Started (edition October 2002) 
 
 Although the reference-subtracted sensorgram shows the actual binding response, it can 
not correct non-specific binding to the dextran matrix of the reference surface, and the 




Regeneration is a process of removing bound analyte from the ligand after interaction 
analysis. This "washing" prepares surface of the sensor chip for the next analysis cycle.  
Process of regeneration can be repeated many times; it depends mainly on nature of the 
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attached ligand. One chip can be usually regenerated 100 times or even more than 1000 
times. 
 
The choice of conditions for regeneration is also dictated by nature and stability of 
ligand and analyte. Different applications may need individual regenerating conditions, 
but most surfaces can be washed with brief pulse of acidic (glycine-HCl) or basic 
(NaOH) solutions. 
 
When the ligand is attached to the surface, regeneration usually doesn't destroy the 
ligand activity, but efficient reconditioning is very important for further successful 
assays. Incomplete regeneration or loss of binding activity will decrease repeatability 
and the lifetime of the sensor chip will be shortened.  
 
 If  the sensor surface is not efficiently regenerated with an extreme pH, other conditions 
may be tested either alone or in combination with high or low pH. These include: 
 up to 100% ethylene glycol 
 high ionic strength (e.g.≤ 5M NaCl or ≤ 4M MgCl2) 
 low concentration of SDS (≤0,5%) 
 
Sometimes it is not necessary to run regeneration. If the analyte dissociates fast enough, 
all analyte can be washed out with running buffer in a reasonable time. This is 
immediately evident from the sensorgram, since the response returns to the baseline 
after the sample injection. 
 
Loading the sample 
 
To avoid dispersion of the sample at the beginning and at the end of injection, a special 
technique of loading the sample is required. It is recommended to introduce small air 
and sample segments (about 5 μl each) into the pipette tip before loading. This separates 




Fig. 11 Air bubble technique for loading the sample – Biacore X; Getting Started (edition October 
2002) 
 
Approximately 20 μl remains in the dead volume between the injection port and the 
loop. It doesn't come to the flow cells, so the minimum of the loading volume has to be 
raised by 20 μl. For clarity, the required total volume is shown at the bottom of the 




BiacoreX Control Software includes an interface to BIAevaluation to help in 
interpreting sensorgram data. BIAevaluation is used for calculations and creation of 
solvent correction plots. It also supplies kinetics and affinity measurements (calculating 
kinetics and affinity constants). 
 This software provides functions for: 
 Comparing sensorgrams from separate runs by generating normalized overlay 
plots 
 Deriving kinetic rate constant from association and dissociation phases of 
sensorgrams 
 Deriving binding rates from sensorgram data, primarily for use in concentration 
measurements (from analyses under conditions where the binding rate is directly 
proportional to the analyte concentration) 
 Evaluating concentration measurement 
 
In this study, the program was used mainly for evaluation, and more close comparison 
of the sensorgrams from reference and active cell, because sometimes the response level 





Steps in the present BIAevaluation: 
1. The current file was opened and only the curves from Fc-1 and Fc-2 were chosen 
(flow cell 1 is the reference cell and flow cell 2 is the active one).  
2. The peaks of regeneration solution were removed by command Edit: Cut 
3. Then the curves were aligned to the same starting point by Calculate: X-transform 
→ Curve Alignment 
4. At the last step the curves were adjusted to a common baseline by Calculate: Y-
transform → Zero at Average of Selection 
 The sensorgrams are now at the same starting point and adjusted to a common baseline, 
and the differences in the response between these two curves are clearly seen. 
 
 
2.3.2 PRACTICE OF THE EXPERIMENTATION 
 
Immobilizing the ligand - coating the chip with PNP (TP) 
 
 1. Preparation of enzyme solution  
  
I weighed app. 50 mg of PNP (TP) powder, which consists of about 50 % of pure PNP 
(TP) and the rest consist of the buffer salts that were present during lyophilization of the 
protein. The salts are first replaced by acetate buffer, by dissolving the material in 1 ml 
of the buffer. Then I made desalting on the small chromatography column Econo-Pac 
10DG Column manual: 
 
 a) Pour out the excess of column preservative buffer from the column. 
 b) Fill it with the 20 ml of needed buffer (till the 30 ml mark), snap off the bottom tip 
and let the buffer drain out until it reaches the top frit. 
 c) Pour in your sample solution in volume of 3,0 ml. If there is a less then 3,0 ml, add 
buffer to get total sample volume.  
 d) Allow the sample to completely run into the column and discard this first 3,0 ml 
eluted. 
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 e) Pour in 4,0 ml of buffer to elute higher molecular weight component(s) while 
collecting the 4,0 ml fraction from the column. [14] 
 
From this pure concentrated sample I prepared solution of required concentration. I 
diluted the sample and then I filtered it through microfilter 0,2 μm. Now the sample is 
prepared for coating the chip. 
 
Biacore X Control Software includes procedures (implemented as pre-defined macros) 
for ligand immobilization. Instructions are given on the screen. Each step of the 
procedure is well-defined in window, including the choice of coupling, standard 
volumes and injection times. 
 
 2. Amine coupling procedure 
 
 Surface activation 
For the amine coupling, surface must be first activated by mixture of N-
hydroxysuccimide (NHS) and N-ethyl-N´-(dimethylaminopropyl)carbodiimide (EDC). 
Aliquots of stock solutions of these, available from Amine coupling kit, are mixed 
together immediately before injection. I used 60 μl of each chemical. Injection takes 7 
minutes when flow rate is 10 μl/min and injected volume of mixture is 70 μl. The 
sample loop has to be loaded with at least 90 μl and air bubble technique has to be used. 
 
 Injection of ligand solution 
 The same net volume (70 μl) of prepared and filtered enzyme solution is injected into 
the loop, after finishing activation of the surface. 
 
 Deactivation 
 Deactivation of remaining active esters in the matrix requires injection of the same net 
volume of 1 M ethanolamine hydrochloride pH 8,5, ready-to-use from Amine coupling 
kit. 
 After finishing this last step, the final operating dialogue box advises to condition the 




Schematic sensorgram for amine coupling: 
 
Fig. 12 A model sensorgram illustrating the distinction between the amount of ligand bound and 
the amount immobilized - SensorSurface_Handbook.pdf (www.biacore.com) 
 
 3. Interpretation of the sensorgram 
 
 When immobilization procedure has ended, the level of immobilized ligand is found 
out by using reference line and by adding report points at appropriate positions (Fig 11). 
At first the reference line must be dragged to the starting baseline of the sensorgram, 
where the first report point is added. This sets the baseline to zero for relative response 
at the other report points. Then the reference line is dragged to a position after 
ethanolamine injection and the second report point is placed there. This response level 
is given relative to the baseline response and represents the amount of the ligand 
covalently bound to the surface. Then the theoretical maximum binding capacity (Rmax) 




 I was testing guanosine as a substrate for PNP in the direction of cleavage reaction and 
guanine and ribose-1-phosphate and deoxyribose-1-phosphate in the direction of 
synthesis. For the TP enzyme I tested mostly thymidine as a substrate, but I also tried 
uridine and deoxy-uridine in one case. I always prepared analyte solutions of two 
different concentrations, 1 mM and 0,1 mM, except in one experiment with thymidine, 
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where I used solution of concentration of 0.2 mM. Appropriate amount of the testing 
substance was weighed out and dissolved in 10 ml of buffer. Buffer was one of the 
variable conditions (see Variation of conditions). The lower concentration was achieved 
by diluting the 1 mM solution ten folds (1:10). These solutions were then filtrated 
through microfilter (0,2 μm) before injecting in the instrument.  
 
Just as in immobilization, each step in interaction analysis is guided window by window 
through the computer-aided operating system. Instructions are given for choosing the 
flow path, flow rate and injected volume of analyte and regeneration solution.  
 
 Starting to run sensorgram begins with choice of parameters. 
1. Detection mode - multichannel in order of flow cells 1-2. (Flow cell 1 is the 
reference cell and flow cell 2 is that one with immobilized PNP.) 
2. Flow rate – 10 μl/ml 
 
Then the injection of analyte solution follows in net volume of 30 μl. After finishing the 
interaction analysis, short pulse of regeneration solution (glycine-HCl, pH 2,5) is 
injected in net volume of 5 μl. Stopping of the sensorgram is possible when the response 
after regeneration is back on the baseline. 
 




The buffer plays two roles in experiments. It serves as a running medium through whole 
system and also as a solvent of analyte (Guo, Gua, etc.) Mostly the same buffer was 
used as running medium and as solvent, but in some cases different buffers were used 







Type of buffer used Molar concentration pH 
HBS-EP buffer 
(available from Biacore) 
10 mM 7,4 
Phosphate buffer 
(K2HPO4 + KH2PO4) 
varies from 1 mM to 50 mM varies from 6,2 to 8,0 
Acetate buffer 
(from Biacore or prepared) 
10 mM 5,0 
 
 
 Specifications of buffers from Biacore are described in more details in MATERIALS. 
 
 
Particular types of Phosphate buffer (K2HPO4 + KH2PO4): 
 Molar concentration pH 
 50 mM 7,2 
 10 mM 6,2 
for PNP trials  6,7 
  7,1-7,3 
  8,0 
 1 mM 7,1 
 50 mM 7,0 
 20 mM 7,2 
for TP trials 10 mM 7,1 
 2 mM 7,1 
 1 mM 7,2 





Usually the basic laboratory temperature of 25ºC was used. In some trials, the 
temperature was increased to 30ºC and 35ºC to observe, whether it influences the 




I used basic flow rate (10 μl/min) in most of the trials. While working with TP enzyme I 
tried to change the flow rate and see, if this has an influence on behaviour of the 
enzyme. One of the new rates was half speed (5 μl/min), and the second was double 
speed (20 μl/min). 
 







3.1 Results from experiments with PNP enzyme 
 
3.1.1 Comparison of immobilizing procedure of PNP enzyme in three different 
concentrations to the surface of the sensor chip. 
 






















Report point table:  
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 2 205.5 5.0 14507.2 0.31 -0.14 0.19 Yes 0 baseline 
1 2 2084.5 5.0 15458.0 0.43 -0.15 0.36 No 950.8 ethanolamine 
 
  
 This is the sensorgam and the report point table of immobilization procedure. The 
sensor chip was coated with solution of PNP in concentration 100 µg/ml dissolved in 
10 mM acetate buffer, pH 4.5. The first peak represents activation by EDC/NHS 
mixture, the second peak represents immobilization of PNP and the third one is 
deactivation of remaining active esters. The drop during immobilizing procedure is 
caused by air bubble, which changed medium in detecting unit and subsequently the 
response in reflection. The sensorgram indicates that the immobilized level is quite low, 
only 950.8 RU.  
 49 
 























Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 2 140.5 5.0 14223.8 0.15 -0.06 0.12 Yes 0 baseline 
1 2 1868.5 5.0 16725.5 0.38 -0.13 0.32 No 2501.7 ethanolamine 
 
 This is the sensorgram and the report point table of immobilization to the second chip. 
There I used higher concentration of PNP – 300 μg/ml on the same conditions – and 
also the level of immobilized enzyme was higher. In comparison with the first sample of 
enzyme, where the concentration was 100 μg/ml and immobilized level was 950.8 RU, 





































Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 2 71.5 5.0 15106.3 0.16 0.00 0.18 Yes 0 baseline 
1 2 1776.5 5.0 17919.9 2.08 -1.02 0.92 No 2813.6 ethanolamine 
 
This is the immobilization of third chip, where the highest concentration of PNP 
(600 μg/ml on the same conditions) was used. In comparison to the previous procedure, 
double increasing of enzyme concentration did not increase the immobilized level in the 
same rate. Relative response of the concentration 300 μg/ml was 2501.7 RU and for 
600 μg/ml was it 2813.6 RU, which is only about app. 300 RU more. 
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3.1.2 Interaction analysis between guanosine dissolved in phosphate buffer and PNP 
enzyme (100 μg/ml) immobilized on the surface of the sensor chip. 
 
Sensorgrams of guanosine 0.1 mM in phosphate buffer 10 mM, pH 7.2 






































































Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 56.5 5 14412.2 0.29 -0.1 0.25 Yes 0 base 
1 2 56.5 5 15385.6 0.3 -0.13 0.18 Yes 0 base 
1 2.1 56.5 5 973.3 0.21 -0.06 0.2 Yes 0 base 
1 1 250.5 5 14524.8 4.12 -1.74 2.82 No 112.6 guo 0.1mM 
1 2 250.5 5 15479.3 1.6 0.8 0.63 No 93.7 guo 0.1mM 
1 2.1 250.5 5 951.7 2.17 1.02 1.17 No -21.6 guo 0.1mM 
 

























Curves show binding of guanosine to PNP in flow cell 2 and non-specific binding of 
guanosine to the dextran matrix on the surface of the sensor chip in flow cell 1, which 
serves as a reference cell. This confrontation shows that relative response from flow cell 
1 is higher than that one from flow cell 2, which indicates that enzyme is either not 
active or the amount immobilized to the chip is insufficient, and only the binding of 
guanosine to the dextran matrix is observable. 
 
3.1.3 Interaction analysis between guanosine dissolved in phosphate buffer of different 
pH values and PNP enzyme. 
 
BIAevaluation plots of 0.1mM guanosine in 10mM buffers of different pH 
 


























The shape of the curve shows binding somehow, but there is again higher non-specific 






















4.10.Guo 0,1mMphos 6.7 Fc 1 - 1 4.10.Guo 0,1mMphos 6.7 Fc 2 - 1
 
 
At this pH 6.7, a big drop occurred and the relative response was negative, -52.7 RU. 
Curves from both the reference and active cells show almost no difference in binding 
levels. 
 





















4.10.(2)Guo 0,1mMphos Fc 1 - 1 4.10.(2)Guo 0,1mMphos Fc 2 - 1
 
 
The binding at pH 7.3 and at pH 8.0 on these two plots looks very similar. The relative 
responses wave along the baseline for both the relative and active curves.  
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5.10.guo 0,1mMphos 8.0 Fc 1 - 1 5.10.guo 0,1mMphos 8.0 Fc 2 - 1
 
 
If we compare the BIAevaluation plots, it is hard to say whether and how the pH 
influences the binding of guanosine to PNP enzyme, because results vary a lot and there 
is no relation. The first two sensorgrams are absolutely different from others and the last 
two seem to be almost of the same shape – like there is minimal binding. 
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3.1.4 Interaction analysis between guanine “dissolved” in HBS-EP buffer with and 
without addition of DMSO and PNP enzyme. 
 
Sensorgrams of 0.1 mM guanine in HBS-EP buffer 
 











































































Sensorgrams of 0.1 mM guanine in HBS-EP buffer with 2% (V/V) of DMSO 
 















































































As sensorgrams clearly show, DMSO caused big change in the response and these great 
peaks in both of the cells totally covered /overlaid any binding of guanine. But the 
guanine was not dissolved even thought there was added 200 µl of DMSO to 10 ml of 





3.1.5 Comparison of BIAevaluation plots from interaction analyses between guanine 
and ribose-1-phosphate or deoxyribose-1-phosphate in one solution (two different 
concentrations) and PNP enzyme (300 μg/ml) fixed on the surface of the sensor chip.  
 




























Report point table 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline  RelResp     Id 
1 1 104.5 5 14133.9   0.28 -0.11 0.21 Yes 0 baseline 
1 2 104.5 5 17079.5   0.39 -0.16 0.28 Yes 0  baseline 
1 1 288.5 5 14159.6   4.12 -1.22 3.84 No               25.6     guo+R-P 
1 2 288.5 5 17096.7             1.79 0.93 0.53 No               17.1     guo+R-P 
 
 
Relative response of 0.1 mM solution of guanine and ribose-1-phosphate is rather low. 
At the beginning of injection there was a decrease in response, but after some time it 
started to increase. In BIAevaluation plot, the curves were aligned to the same starting 


































Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 75.5 5 14130.7             0.33 -0.12 0.27 Yes 0 baseline 
1 2 75.5 5 17053.8   0.39 -0.17 0.24 Yes 0 baseline 
1 1 259.5 5 14201.6           0.81 -17.25 27.93 No 70.9 Guo-R-P 
1 2 259.5 5 17167.3   I.47 0.73 0.59 No  113.4 Guo-R-P 
 
 
In comparison to lower concentration, the relative response of 1 mM solution of 
guanine and ribose-1-phosphate is severalfold higher. The shape of the curves differs 
between concentrations but it is same between both (reference and active) cells. 
Relative response in active sensorgram is higher than that one from reference 
sensorgram, so there might be some binding anyhow. It is also obvious from relative 


































Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 50.5 5.0 14046.4 0.13 -0.05 0.10 Yes 0 baseline 
1 2 50.5 5.0 16820.5 0.18 -0.07 0.13 Yes 0 baseline 
1 1 234.5 5.0 14148.2 51.83 -22.44 33.98 No 101.8 Guo-dR-P 
1 2 234.5 5.0 16951.4 1.16 0.53 0.66 No 130.9 Guo-dR-P 
 
 
In comparison to the experiments with ribose-1-phosphate, these trials with 
deoxyribose-1-phosphate do not significantly differ between concentrations as well as 
between reference and active sensorgrams. The relative response is very high for the 
concentration of 0.1 mM solution and the shapes of curves are same again. If we 
compare plots of poor 0.1 mM deoxyribose-1-phosphate with these plots, they are very 






























Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 51.5 5.0 14046.3 0.24 -0.06 0.23 Yes 0 baseline 
1 2 51.5 5.0 16823.1 0.09 0.02 0.09 Yes 0 baseline 
1 1 235.5 5.0 14160.4 52.84 -22.44 35.86 No 114.2 guo-dR-P 
1 2 235.5 5.0 16977.0 0.95 0.46 0.47 No 153.9 guo-dR-P 
 
 
There is almost no difference between 0.1 mM and 1 mM concentration. Relative units 
are close to those of 0.1 mM guanine and deoxyribose-1-phosphate and also the shape 
of the curves is same again. But anyhow there is some more specific binding in active 
cell as it is shown in BIAevaluation plot. 
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3.2 Results from experiments with TP enzyme 
 
3.2.1 Illustration of immobilizing procedure of TP enzyme 
 






















Report point table: 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 2 37.5 5.0 16514.9 0.25 0.04 0.26 Yes 0 baseline 
1 2 1765.5 5.0 20584.0 1.43 0.58 1.04 No 4069.2 ethanolamine 
 
This is the sensorgram of thymidine phosphorylase immobilizing procedure. The 
immobilized level of TP enzyme (74,75 μg/ml) is 4069,2 RU. In comparison with PNP 
enzyme, TP was used in lower concentration, but the immobilized level achieved was 
much higher.  
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3.2.2 Illustration of interaction analysis between thymidine in solution and TP enzyme 
immobilized on the surface of the sensor chip. 
 
Sensorgrams of thymidine (0.1mM) dissolved in phosphate buffer (1 mM, pH 7.2), temp. 30ºC 
 




























































































0.1mM thymidine in pho Fc 1 - 1 0.1mM thymidine in pho Fc 2 - 1
 
 
There is clearly seen in the BIAevaluation plot, that the binding of thymidine to TP 
enzyme (Fc 2) exceeded the non-specific binding of thymidine to dextran matrix (Fc 1). 






Report point table: 
 
Cycle Fc Time Window AbsResp  SD Slope LRSD Baseline RelResp Id 
1 1 70.5 5 13273.1 0.24 0.04 0.26 Yes 0 baseline 
1 2 70.5 5 17276.4 0.27 0.05 0.28 Yes 0 baseline 
1 2-1 70.5 5 4003.3 0.36 0.13 0.3 Yes 0 baseline 
1 1 257.5 5 13305.8 1.46 0.54 1.19 No 32.6 thymidine 
1 2 257.5 5 17320.7 1.2 0.57 0.61 No 44.3 thymidine 
1 2-1 257.5 5 4016.1 0.81 0.23 0.77 No 12.8 thymidine 
 
 
3.2.3 Comparison of BIAevaluation plots from interaction analyses between thymidine 
and TP enzyme in the usage of different flow rates. 
 
BIAevaluation plots of 0.2 mM thymidine in phosphate buffer 2 mM, pH 7.2  
 


















































0.2mM in 2mMphos_10 Fc  1 - 1 0.2mM in 2mMphos_10 Fc  2 - 1
 
 




























Report point tables: 
 
thymidine 0.2 mM in phosp.buffer 2 mM, flow rate 20 μl/ml 
 
Cycle Fc Time Window AbsResp SD  Slope LRSD Baseline RelResp Id 
1 1 53.5 5 13863.7 0.54 0.07 0.59 Yes 0 baseline 
1 2 53.5 5 17912.5 0.45 0.16 0.38 Yes 0 baseline 
1 1 147.5 5 13881.5 2.37 -0.58 2.36 No 17.7 thymidine 
1 2 147.5 5 17935.3 0.92 0.46 0.34 No 22.7 thymidine 
 
thymidine 0.2mM in phosp.buffer 2mM, flow rate 10 μl/ml 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 52.5 5 13862.8 0.38 0.06 0.4 Yes 0 baseline 
1 2 52.5 5 17918 0.24 0 0.27 Yes 0 baseline 
1 1 244.5 5 13878.9 3.27 -1.25 2.56 No 16.1 thymidine 
1 2 244.5 5 17937 1.56 0.77 0.67 No 19 thymidine 
 
thymidine 0.2mM in phosp.buffer 2mM, flow rate 5 μl/ml 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 56.5 5 13862.2 0.33 0 0.37 Yes 0 baseline 
1 2 56.5 5 17916.5 0.24 -0.08 0.21 Yes 0 baseline 
1 1 422.5 5 13879.5 1.22 0.03 1.37 No 17.3 thymidine 




BIAevaluation plots of 0.2 mM thymidine in phosphate buffer 10 mM, pH 7.2  
 













































































Report point tables: 
 
thymidine 0.2 mM in phosp.buffer 10 mM, flow rate 20 μl/ml 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 96.5 5 14024.9 0.29 -0.11 0.23 Yes 0 baseline 
1 2 96.5 5 18110.5 0.13 -0.01 0.14 Yes 0 baseline 
1 1 191.5 5 14060.7 15.85 -7.01 9.95 No 35.9 thymidine 
1 2 191.5 5 18159   7.95 -2.57 7.08 No 48.6 thymidine 
 
thymidine 0.2 mM in phosp.buffer 10 mM, flow rate 5 μl/ml 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 50.5 5 14026.1 0.41 0.15 0.35 Yes 0 baseline 
1 2 50.5 5 18113.2 0.39 0.03 0.43 Yes 0 baseline 
1 1 421.5 5 14067.2 10.28 -4.29 7.18 No 41.2 thymidine 
1 2 421.5 5 18160.5 0.97 0.47 0.45 No 47.2 thymidine 
 
thymidine 0.2 mM in phosp.buffer 10 mM, flow rate 10 μl/ml 
 
Cycle Fc Time Window AbsResp SD Slope LRSD Baseline RelResp Id 
1 1 93.5 5 14023 0.3 0.08 0.29 Yes 0 baseline 
1 2 93.5 5 18110.8 0.38 0.02 0.43 Yes 0 baseline 
1 1 280.5 5 14064 12.58 -5.31 8.63 No 41 thymidine 
1 2 280.5 5 18159.8 0.89 0.45 0.35 No 49 thymidine 
 
 
These BIAevaluation graphs above compare binding of 0.2 mM thymidine, dissolved in 
2 mM and 10 mM phosphate buffer, to TP enzyme with reference surface at three 
different flow rates. The response from reference cell (red) usually copies the curve 
from active cell (green) or vice versa. There are no significant differences in binding 
between the cells. 
 
The flow rate influences the time, in which the substrate is in contact with the surface of 
the chip, and subsequently with enzyme. But it has no influence on binding of substrate 
to enzyme. 
 
Visible differences are between two molarities of phosphate buffers. The more 
concentrated phosphate buffer gives higher relative responses (in both of the cells) than 





3.2.4 Comparison of BIAevaluation plots from interaction analyses between thymidine 
or uridine or deoxy-uridine and TP enzyme. 
 






























































































































thym 1mM (2) Fc=2-1 - 1 deoxy-uridine 1mM Fc=2-1 - 1 uridine 1mM Fc=2-1 - 1
 
 
 The first part of BIAevaluation plots compare the same substrate of two different  
concentrations and the other part compare three different substrates of the same 
concentration. It is interesting, that lower concentration of the substrate gives better 
responses than higher concentration, except for thymidine. This event is possible to see 
also in the last plot, where thymidine of higher concentration provides the best response 




 In this study I was testing the binding of natural substrates to their enzymes, using the 
different conditions. PNP enzyme was the main object of the investigation, but the 
results were not as satisfactory as was expected, then TP enzyme was also tested. 
 
PNP enzyme 
 At the beginning, a convenient concentration of PNP enzyme was sought for the 
coating of the sensor chip. It is obvious from the results that with the rising 
concentration of enzyme the immobilized level did not increase proportionally. The best 
concentration of PNP enzyme for immobilization procedure was 300 μg/ml.  
 
The conditions during the interaction analyses were changed to find out the best 
environment for the binding of substrates to enzyme. As a natural substrate for PNP 
enzyme we tested mainly guanosine (participating in the way of cleavage), dissolved in 
various concentrations and pH of buffer. In comparison of pH of buffers, none of the pH 
values showed noticeable preferences. In comparison of types of buffers, better results 
were achieved with phosphate buffer than with the HBS-EP buffer. 
 
As other natural substrates we used guanine and at the end also ribose-1-phosphate and 
deoxyribose-1-phosphate.While guanosine was easily dissolved, guanine wasn‟t. It is 
difficult to estimate how much of weighed amount of guanine was in testing solution, 
but some changes in the response occurred, which means that some guanine has bound 
to enzyme. For better dissolving of guanine an organic solvent DMSO was used, but its 
background response was so great, that it covered the sensitive binding of guanine and it 
didn‟t even help with solubility. 
 
TP enzyme 
While testing TP enzyme, usually two concentrations of substrate solutions were 
examined and compared in changing conditions like type and molality of buffer, which 
was used as solvent and running medium, then temperature and flow rate.  
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A great difference appeared in sensorgram when running buffer was dissimilar to that 
used as a solvent for substrate. It caused so big fall in response, that any interaction 
between enzyme and substrate couldn‟t be seen. Concentration of buffer also influenced 
the response. I used mostly phosphate buffer and phosphate ions participate in reaction 
catalyzed by TP. Higher molarity of buffer usually, but not every time, caused bulk shift 
in response level. The best results were obtained when the 1mM phosphate buffer and 
0.1 mM solution of thymidine were used. The reason could be the high sensitivity of 
instrument Biacore X, because then small nuances are more visible than at higher 
concentrations, where the phosphate ions “cover” the binding process.  
 
Increase of temperature didn‟t improve enzyme activity in binding with substrate; it 
only caused undesirable air bubbles in the system. Finally, neither the change of flow 
rate had any effect on substrate-enzyme interaction. Although the flow rate determines 
the time period, during which the substrate is in contact with enzyme, it had no impact 




In this study, the ligand binding properties of two enzymes – purine nucleoside 
phosphorylase and thymidine phosphorylase – were tested, exploiting a method of 
surface plasmon resonance in Biacore X instrument. 
 
PNP is a ubiquitous enzyme playing a key role in the purine salvage pathway and TP 
plays an important role in human organism too, especially in pathological processes like 
inflammation or cancer. Both of enzymes are potential tools for the enzymatic synthesis 
of nucleoside analogues, which may possibly be used as antiviral or anticancer agents 
and that are difficult to prepare by chemical synthesis, or are obtained in a low yields.  
 
Use of Biacore X instrument helps to reveal how the enzymes interact with their natural 
substrates or derivatives. This work was focused on searching for the most suitable 
conditions, at first for immobilizing procedure (coating the surface of the sensor chip 
with PNP and TP enzyme) and then for interaction analysis between the enzymes and 
their natural substrates. The present results can be used as starting point for additional 
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investigations of interaction analyses between enzymes and semi-synthetic analogues or 
they can also contribute to optimize conditions of producing such compounds by 
biocatalysis. In particular, the use of enzymes as biocatalysts allow the stereo- and 
regio-selective formation of the glycosidic bond and application of this technique may 
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7. SUMMARY IN CZECH (SOUHRN PRÁCE) 
 
Tato práce se zabývá zkoumáním vazebných vlastností a interakcí u enzymů 
purinnukleosidfosforylasa a thymidinfosforylasa s jejich přirozenými substráty 
s využitím metody SPR analýzy v přístroji Biacore X.  
 
Cílem práce bylo nejprve zjistit, zda a jak mohou být enzymy, připravené technologií 
rekombinantní DNA, ukotveny na povrch analytického čipu CM 5 s volnými 
karboxylovými skupinami. Poté bylo testováno, jakým způsobem a za jakých podmínek 
se již ukotvené enzymy vážou se svými přirozenými substráty. Měnícími se 
podmínkami byly druh pufru, jeho pH a molalita, teplota v systému a průtoková 
rychlost celou. 
Jako přirozené substráty pro enzym PNP byly použity guanosin ve směru rozkladné 
reakce a guanin s ribóza-1-fosfát nebo s deoxyribóza-1-fosfát ve směru syntézy. Pro 
enzym TP, který byl studován pouze ve směru fosforolýzy, byly jako přirozené 
substráty použity thymidin, uridin, a deoxyuridin.  
 V závěru byla opakována interakční analýza k ověření stability čipu pokrytého TP 
enzymem, který byl uskladněn v lednici po dobu 10 týdnů. 
 
Přístroj Biacore X je založen na metodě SPR analýzy. Surface plasmon resonance 
neboli povrchová plasmonová rezonance je neinvazivní optická metoda sloužící ke 
sledování interakcí mezi biomolekulami a jejich ligandy. Odpověď nezávisí na povaze 
biomolekuly, proto přístroj umožňuje měřit široké spektrum vzorků – od vysoce čistých 
molekul po hrubé vzorky jako jakou viry, bakterie či eukaryotické buňky. Kromě 
klasického analytického stanovení koncentrací analytů lze získat též časový průběh 
reakce interakcí biomolekul, provádět kinetické studie a určovat kinetické parametry 
pro sledované děje. 
Povrchová plasmonová resonance je jev vyskytující se v tenkém vodivém filmu na 
rozhraní dvou medií s odlišným refraktivním indexem. V systému Biacore jsou těmito 
médii sklo senzorového čipu a roztok vzorku. Vodivým filmem je tenká vrstva zlata na 
povrchu čipu. V určité kombinaci úhlu dopadu a vlnové délky dopadajícího světla 
dochází k excitaci plasmonů z vrstvy zlata. Přitom dochází k absorpci energie, což se 
projevuje snížením intenzity odraženého světla. Změny v koncentraci roztoku na 
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povrchu čipu způsobují změny v SPR signálu. Ten je vyjádřen v resonančních 
jednotkách RU, kde jedna RU odpovídá jednomu pikogramu na čtverečný milimetr 
povrchu čipu.  
 
Pro imobilizaci enzymu PNP na povrch senzorového čipu byly testovány tři různé 
koncentrace - 100g/ml, 300g/ml a 600g/ml. Ze získaných výsledků vyplývá, že 
stupeň imobilizace enzymu neodpovídá úměrně vzrůstající koncentraci roztoku a jako 
nejvhodnější byla stanovena koncentrace enzymu 300g/ml. Imobilizace enzymu TP 
probíhala ve srovnání s PNP snadněji. Již relativně nízké koncentrace enzymu v roztoku 
(74,75g/ml) poskytly mnohem vyšší stupeň imobilizace. 
 Při hledání optimálních podmínek pro interakci enzym – substrát byly měněny tyto 
parametry: teplota celého systému, průtoková rychlost celou a zejména pufr – druh, jeho 
pH a molalita. Zvýšení teploty nemělo významný vliv na vazebné vlastnosti enzymů ani 
substrátů; naopak mělo za následek tvorbu nežádoucích vzduchových bublin. 
Zpomalením anebo zrychlením průtoku mobilní fáze s roztokem vzorku detekční celou 
se vazebné vlastnosti opět nijak výrazně nezměnily. Rychlost pouze ovlivnila dobu, po 
kterou byl analyt v kontaktu s enzymem, což se projevilo na „šířce“ grafu, ale tvar 
křivky ovlivněn nebyl. 
Pufr měl v systému dvě funkce. Sloužil jako mobilní fáze a zároveň jako rozpouštědlo 
pro vzorky analytů. Využívala jsem převážně dva druhy fosfátových pufrů – HBS-EP 
pufr od výrobce a mnou připravený fosfátový pufr. Při použití HBS-EP pufru jako 
mobilní fáze a fosfátového pufru jako rozpouštědla pro vzorek došlo k silné odpovědi a 
výraznému poklesu signálu, tudíž jakékoliv vazebné interakce nemohly být 
vyhodnoceny. Molalita pufru se osvědčila spíše nižší a pH pufru kolem 7, tedy 
neutrální. 
Při ověřování stability čipu pokrytého enzymem po určité době uchovávání v chladu 
byla zjištěna velmi zeslabená účinnost enzymu. 
 
 Oba enzymy, purinnukleosidfosforylasa i thymidinfosforylasa, hrají v organismu 
důležitou roli. PNP je klíčovým enzymem v metabolismu purinů, zejména v jejich 
záchranných procesech a TP je významným enzymem patologických procesů jako je 
zánět či rakovina. Podrobné zkoumání těchto enzymů přispívá k jejich využití jako 
biokatalyzátorů pro produkci semi-syntetických purinových či pyrimidinových 
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nukleosidových analogů, které mohou být použity jako potenciální antivirotika či 
kancerostatika. Tyto se obtížně získávají organickou syntézou, která je časově i 
finančně náročná, s nízkými výtěžky a bez stereospecifity produktů.  
 
 Tato práce je součástí výzkumného projektu „Biocatalysts for producing 
pharmaceutical nucleoside analogues“ / „Biokatalyzátory pro produkci farmaceutických 
nukleosidových analogů“, kterého se účastní kromě University of Kuopio též University 
of Helsinky a University of Oulu. 
 
